1.32
price up icon1.54%   0.02
after-market Handel nachbörslich: 1.35 0.03 +2.27%
loading
Schlusskurs vom Vortag:
$1.30
Offen:
$1.3
24-Stunden-Volumen:
3.26M
Relative Volume:
1.45
Marktkapitalisierung:
$1.01B
Einnahmen:
$711.41M
Nettoeinkommen (Verlust:
$-133.73M
KGV:
-6.9474
EPS:
-0.19
Netto-Cashflow:
$-199.99M
1W Leistung:
+3.13%
1M Leistung:
-10.81%
6M Leistung:
+1.54%
1J Leistung:
-15.38%
1-Tages-Spanne:
Value
$1.29
$1.34
1-Wochen-Bereich:
Value
$1.24
$1.35
52-Wochen-Spanne:
Value
$1.11
$2.035

Opko Health Inc Stock (OPK) Company Profile

Name
Firmenname
Opko Health Inc
Name
Telefon
305-575-4181
Name
Adresse
4400 BISCAYNE BLVD., MIAMI, FL
Name
Mitarbeiter
2,997
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
OPK's Discussions on Twitter

Vergleichen Sie OPK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
OPK
Opko Health Inc
1.32 998.01M 711.41M -133.73M -199.99M -0.19
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
587.48 215.18B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
227.39 156.94B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
725.91 55.05B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
151.25 41.12B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
224.90 36.97B 15.90B 1.28B 2.21B 7.2842

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-11-20 Eingeleitet JP Morgan Neutral
2025-10-31 Herabstufung Jefferies Buy → Hold
2025-04-25 Eingeleitet JP Morgan Neutral
2023-06-29 Hochstufung Barrington Research Mkt Perform → Outperform
2022-12-15 Eingeleitet H.C. Wainwright Buy
2022-01-24 Herabstufung Barrington Research Outperform → Mkt Perform
2021-06-21 Eingeleitet Ladenburg Thalmann Buy
2019-11-25 Eingeleitet Piper Jaffray Overweight
2018-03-02 Herabstufung JP Morgan Neutral → Underweight
2017-09-14 Herabstufung JP Morgan Overweight → Neutral
2016-06-21 Bestätigt Standpoint Research Buy
2016-06-03 Eingeleitet Standpoint Research Buy
2016-03-31 Bestätigt Barrington Research Outperform
2015-10-16 Eingeleitet JP Morgan Overweight
2015-09-11 Herabstufung Jefferies Buy → Hold
2015-03-03 Herabstufung Oppenheimer Outperform → Perform
2014-05-12 Bestätigt Oppenheimer Outperform
2014-03-14 Eingeleitet Oppenheimer Outperform
2013-11-13 Bestätigt Ladenburg Thalmann Buy
2013-05-30 Bestätigt Ladenburg Thalmann Buy
2012-10-22 Eingeleitet Barrington Research Outperform
2011-12-01 Bestätigt Ladenburg Thalmann Buy
2011-07-14 Eingeleitet Ladenburg Thalmann Buy
Alle ansehen

Opko Health Inc Aktie (OPK) Neueste Nachrichten

pulisher
Nov 22, 2025

OPKO Health (NASDAQ:OPK) CEO Acquires $771,400.00 in Stock - MarketBeat

Nov 22, 2025
pulisher
Nov 22, 2025

Zacks Research Boosts Earnings Estimates for OPKO Health - MarketBeat

Nov 22, 2025
pulisher
Nov 21, 2025

OPKO Health (NASDAQ:OPK) Earns Neutral Rating from Analysts at JPMorgan Chase & Co. - MarketBeat

Nov 21, 2025
pulisher
Nov 21, 2025

Will OPKO Health Inc. (XCY) stock attract long term capital inflowsJuly 2025 Summary & Daily Price Action Insights - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

OPKO Health (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 580,000 Shares - MarketBeat

Nov 20, 2025
pulisher
Nov 20, 2025

JPMorgan initiates Opko Health stock with Neutral rating By Investing.com - Investing.com Canada

Nov 20, 2025
pulisher
Nov 20, 2025

OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla - Yahoo Finance

Nov 20, 2025
pulisher
Nov 20, 2025

Is OPKO Health Inc. building a consolidation baseWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why pension funds invest in OPKO Health Inc. (XCY) stock2025 Year in Review & Fast Gain Stock Trading Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Phillip Md Et Al Frost Purchases 533,300 Shares of OPKO Health (NASDAQ:OPK) Stock - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

Opko Health Insider Bought Shares Worth $759,115, According to a Recent SEC Filing - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

Regression analysis insights on OPKO Health Inc. performanceDay Trade & Daily Profit Focused Screening - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times

Nov 19, 2025
pulisher
Nov 19, 2025

Is OPKO Health Inc. stock supported by strong fundamentalsWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How reliable is OPKO Health Inc. (XCY) stock dividend growthGDP Growth & Reliable Intraday Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will OPKO Health Inc. (XCY) stock benefit from Fed rate cuts2025 Bull vs Bear & Momentum Based Trading Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why analysts remain bullish on OPKO Health Inc. stockWall Street Watch & Stock Portfolio Risk Control - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Using Bollinger Bands to evaluate OPKO Health Inc.Recession Risk & Long-Term Capital Growth Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Opko Health Insider Bought Shares Worth $737,748, According to a Recent SEC Filing - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

News impact scoring models applied to OPKO Health Inc.Market Performance Report & Weekly Breakout Opportunity Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How OPKO Health Inc. (XCY) stock performs during market turbulence2025 Macro Impact & Verified Momentum Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will OPKO Health Inc. stock see insider buyingQuarterly Trade Report & Step-by-Step Swing Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Risk vs reward if holding onto OPKO Health Inc.Gold Moves & Low Drawdown Trading Strategies - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Opko Health CEO Phillip Frost buys $737,747 in OPK stock By Investing.com - Investing.com Nigeria

Nov 18, 2025
pulisher
Nov 18, 2025

Opko Health CEO Phillip Frost buys $737,747 in OPK stock - Investing.com

Nov 18, 2025
pulisher
Nov 18, 2025

Opko Health Insider Bought Shares Worth $678,906, According to a Recent SEC Filing - MarketScreener

Nov 18, 2025
pulisher
Nov 18, 2025

Will OPKO Health Inc. stock benefit from green energy trendsJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference - GlobeNewswire Inc.

Nov 18, 2025
pulisher
Nov 18, 2025

Will OPKO Health Inc. (XCY) stock beat growth indexesM&A Rumor & Technical Entry and Exit Alerts - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

OPKO Health, Inc. $OPK Shares Sold by Y.D. More Investments Ltd - MarketBeat

Nov 17, 2025
pulisher
Nov 16, 2025

Top chart patterns to watch in OPKO Health Inc.Bull Run & Low Drawdown Investment Ideas - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Is OPKO Health Inc. stock gaining market shareJuly 2025 Closing Moves & High Return Stock Watch Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Can technical indicators confirm OPKO Health Inc.’s reversalInsider Buying & Stepwise Trade Signal Guides - newser.com

Nov 16, 2025

Finanzdaten der Opko Health Inc-Aktie (OPK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$191.25
price up icon 1.94%
diagnostics_research LH
$265.64
price up icon 1.59%
diagnostics_research WAT
$393.99
price up icon 4.06%
diagnostics_research MTD
$1,452.35
price up icon 3.78%
$230.63
price up icon 2.25%
diagnostics_research IQV
$224.90
price up icon 3.59%
Kapitalisierung:     |  Volumen (24h):